摘要
內視鏡逆行性膽胰管造影術（endoscopic retrograde cholangiopancreatography, ERCP）是現今可以用來診斷與治療胰臟、膽囊與其相關構造疾病的一個方式。不過相對於其他的檢查，內視鏡逆行性膽胰管造影術相對還是屬於較具侵入性的檢查，而最常見的併發症為內視鏡逆行性膽胰管造影術造成的胰臟炎（post-ERCP pancreatitis, PEP）。因此，除了熟悉病人狀況以及確認病人符合內視鏡逆行性膽胰管造影術的適應症，也必須了解內視鏡逆行性膽胰管造影術造成的胰臟炎的臨床症狀、診斷標準、處置，以及如何透過有效的方法降低併發症的發生率。
參考文獻
Morales SJ, Sampath K, Gardner TB. A Review of Prevention of Post-ERCP Pancreatitis. Gastroenterol Hepatol(N Y) 2018;14:286-92.
van Wanrooij RLJ, van Hooft JE. Prevention of post-ERCP pancreatitis: NSAID or pancreatic stent or both? Endosc Int Open 2019;7:E869-E70.
Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-93.
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62:102-11.
Tryliskyy Y, Bryce GJ. Post-ERCP pancreatitis: Pathophysiology, early identification and risk stratification. Adv Clin Exp Med 2018;27:149-54.